Skip to Main content Skip to Navigation
Journal articles

Immune checkpoint inhibitor induced thyroid dysfunction is a frequent event post-treatment in NSCLC

Nanruoyi Zhou 1 Maria Velez 1 Benjamin Bachrach 1 Jaklin Gukasyan 1 Charlene Fares 1 Amy Cummings 1 Jackson Lind-Lebuffe 1 Wisdom Akingbemi 1 Debory Li 1 Paige Brodrick 1 Nawal yessuf 1 Sarah Rettinger 2 Tristan Grogan 1 Philippe Rochigneux 3, 4, 1 Jonathan Goldman 1 Edward Garon 1 Aaron Lisberg 1 
1 UCLA - University of California [Los Angeles]
2 Providence Hlth & Serv
3 Institut Paoli-Calmettes
4 CRCM - Centre de Recherche en Cancérologie de Marseille
Document type :
Journal articles
Complete list of metadata
https://hal-amu.archives-ouvertes.fr/hal-03689919
Contributor : Philippe ROCHIGNEUX Connect in order to contact the contributor
Submitted on : Tuesday, June 7, 2022 - 4:41:45 PM
Last modification on : Wednesday, June 8, 2022 - 2:59:25 PM

Links full text

pubmedcentral

Identifiers

Collections

INSERM | CNRS | UNIV-AMU | CRCM

Citation

Nanruoyi Zhou, Maria Velez, Benjamin Bachrach, Jaklin Gukasyan, Charlene Fares, et al.. Immune checkpoint inhibitor induced thyroid dysfunction is a frequent event post-treatment in NSCLC. Lung Cancer, Elsevier, 2021, 161, pp.34-41. ⟨10.1016/j.lungcan.2021.08.009⟩. ⟨hal-03689919⟩

Export

BibTeX TEI DC DCterms EndNote Datacite

Share

Metrics

Record views

0